Video
Dr. Hannan on role of stereotactic radiotherapy for kidney cancer in community setting
Author(s):
Video Player is loading.
At the SUO 23rd Annual Meeting, Raquibul Hannan, MD, PhD, described how community urologists can use stereotactic radiotherapy as a tool in their armamentarium for patients with renal cell carcinoma. Hannan is a professor in the Department of Radiation Oncology, Urology and Immunology at the University of Texas Southwestern Medical Center in Dallas.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
Thomas Powles, MBBS, MRCP, MD, on efficacy of sasanlimab plus BCG in BCG-naïve NMIBC
Andrew Armstrong, MD, shares 5-year data on enzalutamide plus ADT in mHSPC
Professor Dickon Hayne on bladder cancer data to watch for at ASCO 2025
Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Related Content
